Jeff Yass’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-47,540
| Closed | -$3.24M | – | 14656 |
|
|
2022
Q3 | $3.24M | Buy |
47,540
+32,468
| +215% | +$1.79M | ﹤0.01% | 3929 |
|
|
2022
Q2 | $482K | Sell |
15,072
-39,883
| -73% | -$1.17M | ﹤0.01% | 8354 |
|
|
2022
Q1 | $1.9M | Sell |
54,955
-73,037
| -57% | -$2.18M | ﹤0.01% | 5589 |
|
|
2021
Q4 | $3.75M | Sell |
127,992
-47,693
| -27% | -$1.48M | ﹤0.01% | 4254 |
|
|
2021
Q3 | $4.48M | Buy |
175,685
+9,281
| +6% | +$273K | ﹤0.01% | 4164 |
|
|
2021
Q2 | $5.83M | Buy |
166,404
+42,376
| +34% | +$1.65M | ﹤0.01% | 3750 |
|
|
2021
Q1 | $5.05M | Buy |
124,028
+31,059
| +33% | +$1.43M | ﹤0.01% | 3896 |
|
|
2020
Q4 | $4.03M | Sell |
92,969
-103,851
| -53% | -$5.12M | ﹤0.01% | 3797 |
|
|
2020
Q3 | $10.9M | Buy |
196,820
+87,939
| +81% | +$5.59M | ﹤0.01% | 2077 |
|
|
2020
Q2 | $6.87M | Sell |
108,881
-50,767
| -32% | -$3.48M | ﹤0.01% | 2592 |
|
|
2020
Q1 | $8.16M | Buy |
159,648
+127,411
| +395% | +$8.53M | ﹤0.01% | 1978 |
|
|
2019
Q4 | $2.56M | Sell |
32,237
-189,207
| -85% | -$11.2M | ﹤0.01% | 3929 |
|
|
2019
Q3 | $10.7M | Sell |
221,444
-699
| -0.3% | -$36.4K | ﹤0.01% | 1897 |
|
|
2019
Q2 | $11.7M | Buy |
+222,143
| New | +$12.8M | ﹤0.01% | 1741 |
|
|
2019
Q1 | – | Sell |
-208,468
| Closed | -$10.2M | – | 10166 |
|
|
2018
Q4 | $8.56M | Buy |
208,468
+174,544
| +515% | +$6.54M | ﹤0.01% | 1756 |
|
|
2018
Q3 | $1.29M | Sell |
33,924
-203,885
| -86% | -$9.03M | ﹤0.01% | 4758 |
|
|
2018
Q2 | $10.7M | Buy |
+237,809
| New | +$10.8M | ﹤0.01% | 1861 |
|
|
2018
Q1 | – | Sell |
-116,424
| Closed | -$6.49M | – | 10467 |
|
|
2017
Q4 | $4.58M | Buy |
+116,424
| New | +$4.35M | ﹤0.01% | 2633 |
|
|
2017
Q2 | – | Sell |
-95,230
| Closed | -$2.83M | – | 10043 |
|
|
2017
Q1 | $3.51M | Buy |
+95,230
| New | +$2.4M | ﹤0.01% | 2794 |
|
|
2016
Q3 | – | Sell |
-48,495
| Closed | -$924K | – | 9251 |
|
|
2016
Q2 | $805K | Buy |
+48,495
| New | +$978K | ﹤0.01% | 5285 |
|
|
2015
Q4 | – | Sell |
-10,912
| Closed | -$460K | – | 10162 |
|
|
2015
Q3 | $460K | Buy |
+10,912
| New | +$515K | ﹤0.01% | 7285 |
|
Other funds holding GBT
Jeff Yass's GBT Position: Q4 2022 in Review
Jeff Yass sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 47,540 shares — an estimated $3.24M sold.
Jeff Yass first reported a position in GBT in Q3 2015 and held it in 21 quarters. The position peaked at $11.7M in Q2 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Jeff Yass reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Jeff Yass sold 47,540 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3.24M.
- Jeff Yass first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 21 quarters.
- Jeff Yass's Global Blood Therapeutics, Inc. position peaked at $11.7M in Q2 2019.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.